Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer

Cancer Research

Volumn 71, Issue 4, 2011, Pages 1263-1271

  Tosolini, Marie ^a,b,c   Kirilovsky, Amos ^a,b,c   Mlecnik, Bernhard ^a,b,c   Fredriksen, Tessa ^a,b,c   Mauger, Stéphanie ^a,b,c   Bindea, Gabriela ^a,b,c   Berger, Anne ^d   Bruneval, Patrick ^d   Fridman, Wolf Herman ^b,c,d   Pagès, Franck ^a,b,c,d   Galon, Jérôme ^a,b,c,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULYSIN; GRANZYME B; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 4; INTERLEUKIN 5; PERFORIN; PERFORIN 1; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT4 PROTEIN; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CANCER RELAPSE; CANCER SURVIVAL; CANCER TISSUE; CD8+ T LYMPHOCYTE; CELL DENSITY; CELLULAR IMMUNITY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE RESPONSE; CYTOTOXIC T LYMPHOCYTE; DISEASE FREE SURVIVAL; FROZEN SECTION; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; TUMOR IMMUNITY;

CARCINOMA; COHORT STUDIES; COLORECTAL NEOPLASMS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-4; LYMPHOCYTES, TUMOR-INFILTRATING; MICROARRAY ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH17 CELLS; TH2 CELLS; TISSUE ARRAY ANALYSIS;

EID: 79951815749     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2907     Document Type: Article

References (36)

1. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004;22:329-60. (Pubitemid 38680426)
2. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature 2004;431:405-6. (Pubitemid 39329565)
3. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7. (Pubitemid 36019639)
4. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960-4. (Pubitemid 44498003)
5. Marrogi AJ, Munshi A, Merogi AJ, et al. Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer 1997;74:492-501. (Pubitemid 27486505)
6. Menegaz RA, Michelin MA, Etchebehere RM, Fernandes PC, Murta EF. Peri- and intratumoral T and B lymphocytic infiltration in breast cancer. Eur J Gynaecol Oncol 2008;29:321-6.
7. Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 2008;14: 5220-7.
8. Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008;26:4410-7.
9. Hiraoka K, Miyamoto M, Cho Y, et al. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in nonsmall- cell lung carcinoma. Br J Cancer 2006;94:275-80. (Pubitemid 43151547)
10. Ito N, Suzuki Y, Taniguchi Y, Ishiguro K, Nakamura H, Ohgi S. Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer. Anticancer Res 2005;25:2027-31. (Pubitemid 40904599)
11. Kawai O, Ishii G, Kubota K, et al. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 2008;113:1387-95.
12. Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005;353:2654-66. (Pubitemid 41817714)
13. Camus M, Tosolini M, Mlecnik B, et al. Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res 2009;69:2685-93.
14. Mlecnik B, Tosolini M, Charoentong P, et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology 2010;138:1429-40.
15. Menzies-Gow A, Ying S, Sabroe I, et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 2002;169:2712-8. (Pubitemid 34921020)
16. Ponath PD, Qin S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-12. (Pubitemid 26057077)
17. Sabroe I, Hartnell A, Jopling LA, et al. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol 1999;162:2946-55. (Pubitemid 29309323)
18. Guidoboni M, Gafa R, Viel A, et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 2001;159:297-304. (Pubitemid 33704214)
19. Lee HE, Chae SW, Lee YJ, et al. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer 2008;99:1704-11.
20. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997;182:318-24. (Pubitemid 27285785)
21. Zhang B, Rong G, Wei H, et al. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 2008;374:533-7.
22. Kryczek I, Banerjee M, Cheng P, et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009;114:1141-9.
23. Kryczek I, Bruce AT, Gudjonsson JE, et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 2008;181:4733-41.
24. Osawa E, Nakajima A, Fujisawa T, et al. Predominant T helper type 2- inflammatory responses promote murine colon cancers. Int J Cancer 2006;118:2232-6.
25. Ziegler A, Heidenreich R, Braumuller H, et al. EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion. Blood 2009;113:3494-502.
26. Evans CF, Galustian C, Bodman-Smith M, Dalgleish A, Kumar D. The effect of colorectal cancer upon host peripheral immune cell function. Colorectal Dis 2010;12:561-9.
27. Kemp RA, Ronchese F. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J Immunol 2001;167:6497-502. (Pubitemid 33081584)
28. Adams SF, Levine DA, Cadungog MG, et al. Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer. Cancer 2009;115:2891-902.
29. Merlo A, Casalini P, Carcangiu ML, et al. FOXP3 expression and overall survival in breast cancer. J Clin Oncol 2009;27:1746-52.
30. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-9. (Pubitemid 39273735)
31. Loddenkemper C, Schernus M, Noutsias M, Stein H, Thiel E, Nagorsen D. In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer. J Transl Med 2006;4:52-9.
32. Salama P, Phillips M, Grieu F, et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009;27:186-92.
33. Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 2009;106:1903-8.
34. Hoffmann P, Boeld TJ, Eder R, et al. Loss of FOXP3 expression in natural human CD4+CD25 +regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009;39:1088-97.
35. Ziegler SF. FOXP3: not just for regulatory T cells anymore. Eur J Immunol 2007;37:21-3. (Pubitemid 46128782)
36. Mlecnik B, Sanchez-Cabo F, Charoentong P, et al. Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction. BMC Genomics 2010; 11 Suppl 1:S7.